Angela Tanudra, MS (she/her/hers)

Associate Director Clinical Sciences
Innoviva Specialty Therapeutics, Inc.

Disclosure(s): Innoviva Specialty Therapeutics, Inc: employee, Stocks/Bonds (Public Company)

Poster(s):

• (P-443) Population Pharmacokinetics (PPK) Analysis of Eravacycline (ERV) to Support Dose Selection for a Trial in Pediatric Patients Aged 8 to Less Than 18 Years with Complicated Intra-Abdominal Infection (cIAI)
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-444) Population Pharmacokinetics (PPK) Analysis of Sulbactam-Durlobactam (SUD) to Support Dose Selection for Evaluation in a Clinical Trial in Pediatric Patients with Acinetobacter Baumannii-Calcoaceticus Complex (ABC) Infections
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET